2024-10-23 14:33:48
Austar Lifesciences Announces 2022 Interim Results
Corporate/ 2023-07-24
Austar Lifesciences Announces 2022 Inter...

Benefiting from the Growth in the Business Segment of Liquid and Bioprocess System and the Increased Capability of Comprehensive Integrated ...

New treatment for rare cancer cholangiocarcinoma approved in Australia
Health/ 2023-07-22
New treatment for rare cancer cholangioc...

Available to treat adults with locally advanced or metastatic cholangiocarcinoma with an FGFR2 fusion or rearrangement

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release